CAT# | CPM-1-0041 |
Sequence | VMAPRTLVL |
Size | 50 Test, 100 Test | Antigen | Virus | Epitope Origin | HLA-A leader3-11 | MHC Restriction | HLA-E_01_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0701 | HLA-A_02_01 DKK1 P3 tetramer-YLGAAGATYV-PE labeled | Inquiry | ||
CPM-1-0296 | HLA-A_24_02 GPC3 tetramer-EYILSLEEL-APC labeled | Inquiry | ||
CPM-1-0068 | HLA-A_24_02 Negative (HIV env) tetramer-RYLRDQQLL-PE labeled | Inquiry | ||
CPM-1-0360 | HLA-B_08_01 CMV IE1 tetramer-QIKVRVDMV-BV421 labeled | Inquiry | ||
CPM-1-0415 | HLA-A_03_01 HPV E6 tetramer-KLCLRFLSK-BV421 labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Cetrorelix acetate (C70H92ClN17O14, referred to as cetrorelix), a synthetic decapeptide with 5 amino acids in th ...
Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...
Antazoline is a drug used in the treatment of atrial fibrillation (AF), and its formula is C17H19N3. In fact, th ...
DAPTA (D-[Ala]-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-amide), D-Ala-Peptide T amide, is one of analogue of peptide T, which ...
Dynorphin A (1-13) [Dyn-A (1-13)] is a short-chain polypeptide containing 13 amino acids and having extensive bi ...